Evidence map›Paper›PMID 31657553›Full record

ArticleChemical research in toxicology2019

Iron Oxide Nanoparticle-Induced Neoplastic-Like Cell Transformation

Tiffany G Kornberg, Todd A Stueckle, Jayme Coyle, Raymond Derk, Philip Demokritou, Yon Rojanasakul, Liying W Rojanasakul

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Magnetic Hyperthermia via ZnPharmaceutics · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Whither Magnetic Hyperthermia? A Tentative Roadmap.Materials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tiffany G KornbergDepartment of Pharmaceutical and Pharmacological Sciences, School of Pharmacy , West Virginia University , Morgantown , West Virginia 26506 , United States.ORCID 0000-0002-6535-3128
Todd A StueckleAllergy and Clinical Immunology Branch, Health Effects Laboratory Division , National Institute for Occupational Safety and Health , Morgantown , West Virginia 26505 , United States.
Jayme CoyleAllergy and Clinical Immunology Branch, Health Effects Laboratory Division , National Institute for Occupational Safety and Health , Morgantown , West Virginia 26505 , United States.
Raymond DerkAllergy and Clinical Immunology Branch, Health Effects Laboratory Division , National Institute for Occupational Safety and Health , Morgantown , West Virginia 26505 , United States.
Philip DemokritouCenter for Nanotechnology and Nanotoxicology, Department of Environmental Health, T.H. Chan School of Public Health , Harvard University , Boston , Massachusetts 02115 , United States.
Yon RojanasakulDepartment of Pharmaceutical and Pharmacological Sciences, School of Pharmacy , West Virginia University , Morgantown , West Virginia 26506 , United States.
Liying W RojanasakulDepartment of Pharmaceutical and Pharmacological Sciences, School of Pharmacy , West Virginia University , Morgantown , West Virginia 26506 , United States.
National Institute for Occupational Safety and Health · USWest Virginia University · USHarvard University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Iron oxide nanoparticles (IONP) have recently surged in production and use in a wide variety of biomedical and environmental applications. However, their potential long-term health effects, including carcinogenesis, are unknown. Limited research suggests IONP can induce genotoxicity and neoplastic transformation associated with particle dissolution and release of free iron ions. "Safe by design" strategies involve the modification of particle physicochemical properties to affect subsequent adverse outcomes, such as an amorphous silica coating to reduce IONP dissolution and direct interaction with cells. We hypothesized that long-term exposure to a specific IONP (nFe

Indexed as

CarcinogensCell ProliferationCell Transformation, NeoplasticDNADNA DamageEpithelial CellsFerric CompoundsHumansMetal NanoparticlesReactive Oxygen SpeciesSilicon DioxideCarcinogensDNAFerric Compoundsferric oxideReactive Oxygen SpeciesSilicon Dioxide

Identifiers

PMID31657553
PMCPMC7457399
OpenAlexW2981928739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.